"Old School" Islet Purification Based on the Unit Gravity Sedimentation as a Rescue Technique for Intraportal Islet Transplantation-A Case Report.
diabetes
islet transplantation
Journal
Cell transplantation
ISSN: 1555-3892
Titre abrégé: Cell Transplant
Pays: United States
ID NLM: 9208854
Informations de publication
Date de publication:
Historique:
entrez:
5
8
2020
pubmed:
5
8
2020
medline:
20
7
2021
Statut:
ppublish
Résumé
Here, we present a case that required a supplemental "old school" islet purification for a safe intraportal infusion. Following pancreas procurement from a brain-dead 26-year-old male donor (body mass index: 21.9), 24.6 ml of islet tissue was isolated after continuous density gradient centrifugation. The islet yield was 504,000 islet equivalent (IEQ), distributed among the following three fractions: 64,161 IEQ in 0.6 ml of pellet, 182,058 IEQ in 10 ml, and 258,010 IEQ in 14 ml with 95%, 20%, and 10% purity, respectively. After a 23-h culture, we applied supplemental islet purification, based on the separation of tissue subfractions during unit gravity sedimentation, a technique developed over 60 years ago ("old school"). This method enabled the reduction of the total pellet volume to 11.6 ml, while retaining 374,940 IEQ with a viability of over 90%. The final islet product was prepared in three infusion bags, containing 130,926 IEQ in 2.6 ml of pellet, 108,079 IEQ in 4 ml of pellet, and 135,935 IEQ in 5 ml of pellet with 65%, 40%, and 30% purity, respectively, and with the addition of unfractionated heparin (70 units/kg body weight). Upon the islet infusion from all three bags, portal pressure increased from 7 to 16 mmHg. Antithrombotic prophylaxis with heparin was continued for 48 h after the infusion, with target activated partial thromboplastin time 50-60 s, followed by fractionated heparin subcutaneous injections for 2 weeks. β-Cell graft function assessed on day 75 post-transplantation was good, according to Igls criteria, with complete elimination of severe hypoglycemic episodes and 50% reduction in insulin requirements. Time spent within the target glucose range (70-180 mg/dl) improved from 42% to 98% and HbA1c declined from 8.7% to 6.7%. Supplemental "old school" islet purification allowed for the safe and successful utilization of a robust and high-quality islet preparation, which otherwise would have been discarded.
Identifiants
pubmed: 32749147
doi: 10.1177/0963689720947098
pmc: PMC7563026
doi:
Types de publication
Case Reports
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
963689720947098Subventions
Organisme : NIDDK NIH HHS
ID : P30 DK020595
Pays : United States
Références
Transplantation. 2011 Dec 15;92(11):1222-30
pubmed: 22089666
CellR4 Repair Replace Regen Reprogram. 2014;2(2):
pubmed: 30581890
Transplantation. 2000 Mar 15;69(5):756-61
pubmed: 10755522
Transplant Proc. 2004 Nov;36(9):2849-54
pubmed: 15621166
CellR4 Repair Replace Regen Reprogram. 2014;2(3):
pubmed: 30613695
J Mol Med (Berl). 1999 Jan;77(1):45-8
pubmed: 9930926
Biochem Biophys Res Commun. 1977 Dec 7;79(3):823-8
pubmed: 202276
J Surg Res. 1988 Nov;45(5):432-42
pubmed: 3141720
CellR4 Repair Replace Regen Reprogram. 2015;3(1):
pubmed: 30613705
Transplant Proc. 2011 Nov;43(9):3181-3
pubmed: 22099751
Diabetes. 2004 Jun;53(6):1407-11
pubmed: 15161741
Transpl Int. 2018 Apr;31(4):343-352
pubmed: 29453879
Diabetes. 2016 Nov;65(11):3418-3428
pubmed: 27465220
Am J Transplant. 2018 Apr;18(4):945-951
pubmed: 28941330
Transplantation. 1991 Sep;52(3):450-2
pubmed: 1716795
CellR4 Repair Replace Regen Reprogram. 2014;2(3):
pubmed: 30613690
Transplantation. 2009 Jun 15;87(11):1629-35
pubmed: 19502953
CellR4 Repair Replace Regen Reprogram. 2014;2(3):
pubmed: 30720967
CellR4 Repair Replace Regen Reprogram. 2014;2(3):
pubmed: 30613694
Am J Transplant. 2019 Mar;19(3):831-843
pubmed: 30203908
PLoS One. 2019 Jul 19;14(7):e0220064
pubmed: 31323061
Transplant Proc. 2010 Jul-Aug;42(6):2024-6
pubmed: 20692398
Ups J Med Sci. 2000;105(2):125-33
pubmed: 11095109
Diabetologia. 2006 Aug;49(8):1845-54
pubmed: 16783471
Transplantation. 1993 Mar;55(3):661-3
pubmed: 8456488
J Clin Endocrinol Metab. 2015 Jun;100(6):2314-21
pubmed: 25816051
Cell Transplant. 2019 Feb;28(2):185-194
pubmed: 30520321
Cell Transplant. 2016;25(8):1515-1523
pubmed: 26922947
CellR4 Repair Replace Regen Reprogram. 2014;2(3):
pubmed: 30613688
Transplantation. 2002 Oct 15;74(7):913-5
pubmed: 12394830
Front Med (Lausanne). 2018 Jul 13;5:202
pubmed: 30057900
Diabetologia. 2009 Mar;52(3):477-85
pubmed: 19130038
Transplant Proc. 1992 Dec;24(6):2796-7
pubmed: 1465944
Transpl Int. 2003 Sep;16(9):613-32
pubmed: 12928769
Biotechnol Genet Eng Rev. 2012;28:101-14
pubmed: 22616483
Cytotechnology. 2015 Mar;67(2):199-206
pubmed: 24443076
Am J Transplant. 2005 Jan;5(1):21-30
pubmed: 15636608
Transplant Proc. 2011 Nov;43(9):3161-6
pubmed: 22099746
Cell Transplant. 2009;18(1):13-22
pubmed: 19476205
Diabetes. 2001 Nov;50(11):2464-71
pubmed: 11679423
Adv Exp Med Biol. 2016;938:1-9
pubmed: 27586418